Barrington Research Forecasts Strong Price Appreciation for Merit Medical Systems (NASDAQ:MMSI) Stock

Merit Medical Systems (NASDAQ:MMSI) had its price objective lifted by equities research analysts at Barrington Research from $106.00 to $109.00 in a research note issued to investors on Wednesday,Benzinga reports. The brokerage currently has an “outperform” rating on the medical instruments supplier’s stock. Barrington Research’s price target would indicate a potential upside of 37.57% from the company’s previous close.

Several other brokerages have also recently commented on MMSI. Piper Sandler lowered their target price on shares of Merit Medical Systems from $113.00 to $106.00 and set an “overweight” rating on the stock in a report on Wednesday, February 18th. Needham & Company LLC lowered their price objective on Merit Medical Systems from $108.00 to $101.00 and set a “buy” rating on the stock in a research note on Wednesday. BTIG Research assumed coverage on Merit Medical Systems in a report on Friday, February 6th. They issued a “buy” rating and a $107.00 price objective for the company. Zacks Research lowered Merit Medical Systems from a “strong-buy” rating to a “hold” rating in a report on Tuesday, November 18th. Finally, Wells Fargo & Company dropped their price target on Merit Medical Systems from $103.00 to $95.00 and set an “overweight” rating for the company in a research note on Friday, November 14th. Nine analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company. According to data from MarketBeat, Merit Medical Systems currently has an average rating of “Moderate Buy” and a consensus target price of $105.22.

Merit Medical Systems Stock Performance

Shares of MMSI traded down $3.20 during midday trading on Wednesday, reaching $79.23. 1,235,115 shares of the stock were exchanged, compared to its average volume of 746,656. Merit Medical Systems has a twelve month low of $77.62 and a twelve month high of $107.27. The company has a quick ratio of 2.86, a current ratio of 4.28 and a debt-to-equity ratio of 0.48. The company has a market cap of $4.70 billion, a P/E ratio of 40.63, a PEG ratio of 2.22 and a beta of 0.61. The stock’s 50 day simple moving average is $84.08 and its 200 day simple moving average is $84.98.

Merit Medical Systems (NASDAQ:MMSI) last released its quarterly earnings results on Tuesday, February 24th. The medical instruments supplier reported $1.04 EPS for the quarter, beating the consensus estimate of $0.96 by $0.08. Merit Medical Systems had a net margin of 8.02% and a return on equity of 14.27%. The business had revenue of $393.94 million for the quarter, compared to the consensus estimate of $390.77 million. During the same period in the prior year, the company posted $0.93 earnings per share. Merit Medical Systems’s revenue was up 10.9% compared to the same quarter last year. Merit Medical Systems has set its FY 2026 guidance at 4.010-4.150 EPS. On average, sell-side analysts expect that Merit Medical Systems will post 3.37 earnings per share for the current year.

Institutional Trading of Merit Medical Systems

A number of hedge funds and other institutional investors have recently modified their holdings of the stock. Assenagon Asset Management S.A. acquired a new stake in shares of Merit Medical Systems during the third quarter valued at about $1,644,000. Norges Bank bought a new position in Merit Medical Systems in the 2nd quarter valued at approximately $53,697,000. Fort Washington Investment Advisors Inc. OH boosted its position in Merit Medical Systems by 69.7% during the 3rd quarter. Fort Washington Investment Advisors Inc. OH now owns 301,718 shares of the medical instruments supplier’s stock worth $25,112,000 after buying an additional 123,912 shares during the period. Envestnet Asset Management Inc. grew its stake in shares of Merit Medical Systems by 5.3% in the second quarter. Envestnet Asset Management Inc. now owns 244,163 shares of the medical instruments supplier’s stock worth $22,824,000 after purchasing an additional 12,256 shares during the last quarter. Finally, Westwood Holdings Group Inc. increased its position in Merit Medical Systems by 11.9% during the 2nd quarter. Westwood Holdings Group Inc. now owns 768,970 shares of the medical instruments supplier’s stock valued at $71,883,000 after purchasing an additional 81,469 shares during the period. Institutional investors own 99.66% of the company’s stock.

Key Stories Impacting Merit Medical Systems

Here are the key news stories impacting Merit Medical Systems this week:

• Positive Sentiment: Q4 beat — Merit reported EPS of $1.04 (vs. $0.96 est.) and revenue of $393.9M, with margin expansion driven by Cardiovascular and strong U.S. and EMEA sales. This confirms durable demand and explains the initial positive market reaction. Merit Medical Q4 Earnings & Revenues Beat Estimate, Margins Expand
• Positive Sentiment: Raised FY‑2026 outlook — Management set EPS guidance of $4.01–$4.15, above consensus (~$3.73), signaling confidence in growth and margins for the year and supporting longer‑term earnings expectations. Press Release / Slide Deck
• Neutral Sentiment: Guidance + strategic moves — Management projects 6%–8% revenue growth for 2026 and plans to divest the DualCap business while reallocating resources to strengthen global platforms; this could streamline operations but may create short‑term execution risk. Merit Medical projects 6%-8% revenue growth for 2026 while divesting DualCap and strengthening global platforms
• Neutral Sentiment: Earnings call color — Management highlighted strong revenue mix and margin drivers in the Q4 call; useful detail for modeling but largely confirms the headline beat rather than changing the story. Merit Medical Systems Inc (MMSI) Q4 2025 Earnings Call Highlights
• Negative Sentiment: Analyst price‑target cut — Needham lowered its price target (from $108 to $101) while keeping a Buy rating, which reduces near‑term upside expectations and may prompt some profit‑taking despite the maintained buy stance. Benzinga note on Needham price target

Merit Medical Systems Company Profile

Merit Medical Systems, Inc is a global manufacturer and marketer of a broad range of medical devices used in diagnostic and interventional procedures. The company’s product portfolio encompasses vascular access, drainage, embolotherapy, and interventional oncology devices, as well as radiofrequency ablation systems and hemostasis solutions. These products serve physicians and hospitals in critical care settings and support minimally invasive treatment options across multiple specialties, including cardiology, radiology, oncology, neurology and endoscopy.

Founded in 1987 by Fred Lampropoulos, Merit Medical Systems has grown through both organic development and targeted acquisitions to expand its technology offerings and geographic reach.